GlassScriptPhysician profile
Eleanor C Brandon
NPI 1740821875
$645.76
in general payments reported to CMS, 2019-2025
11 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.75 · 2022: $74.05 · 2023: $228 · 2024: $82.99 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $132.15 | 2023 | Acumed |
| Amgen INC. | $121.75 | 2025 | Krystexxa |
| Endo Pharmaceuticals INC. | $78.26 | 2021-2023 | Xiaflex |
| Boston Scientific Corporation | $77.48 | 2024-2025 | General - Pain Management |
| Pacira Pharmaceuticals Incorporated | $47.18 | 2022-2023 | Exparel, Zilretta, Iovera |
| Kowa Pharmaceuticals America, INC. | $39.55 | 2022 | |
| Endo USA, INC. | $35.96 | 2024 | Xiaflex |
| Axogen | $35.37 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $32.59 | 2025 | |
| Sanara Medtech INC. | $27.34 | 2023 | Celleraterx |
| Stryker Corporation | $18.13 | 2025 | Pangea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eleanor Brandon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.